Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Genetic discoveries are leading to new treatments for alopecia areata.

New understanding and treatments for hair loss are improving, but more research is needed.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

More precise, personalized therapies are needed for autoimmune diseases.

Certain genes are linked to the risk of developing Alopecia Areata.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.